Monica Locatelli Selected Research

Monica Locatelli Research Topics

Disease

8	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 03/2013
7	Albuminuria 01/2022 - 03/2013
5	Hemolytic-Uremic Syndrome 01/2022 - 07/2008
5	Proteinuria 01/2020 - 01/2013
4	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 07/2008
4	Inflammation (Inflammations) 10/2019 - 10/2012
3	Thrombosis (Thrombus) 01/2022 - 07/2011
3	Chronic Renal Insufficiency 01/2020 - 03/2013
2	Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency) 01/2021 - 01/2016
2	Dyslipidemias (Dyslipidemia) 01/2021 - 03/2013
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 03/2013
2	Fibrosis (Cirrhosis) 10/2019 - 01/2017
2	Diarrhea 10/2012 - 07/2011
2	Thrombocytopenia (Thrombopenia) 10/2012 - 07/2011
2	Hemolytic Anemia 10/2012 - 07/2011
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Kidney Diseases (Kidney Disease) 01/2021
1	Microvascular Rarefaction 10/2019
1	Cardiac Arrhythmias (Arrythmia) 10/2018
1	Nephrosis 01/2016
1	Sclerosis 01/2016
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2016
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2015
1	Cysts 01/2015
1	Renal Insufficiency (Renal Failure) 01/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2014
1	Body Weight (Weight, Body) 03/2013
1	Neoplasms (Cancer) 11/2009

Drug/Important Bio-Agent (IBA)

4	Shiga Toxin (Shigella Toxin)IBA 01/2022 - 07/2011
4	Complement System Proteins (Complement)IBA 12/2020 - 07/2011
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2018 - 01/2016
3	AntioxidantsIBA 10/2014 - 11/2009
2	nephrinIBA 01/2022 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2015
2	ThrombomodulinIBA 10/2012 - 07/2011
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	empagliflozinIBA 01/2022
1	Shiga Toxin 2IBA 01/2022
1	NestinIBA 01/2022
1	LipidsIBA 01/2021
1	CER-001IBA 01/2021
1	Conditioned Culture MediaIBA 01/2020
1	honokiolIBA 01/2020
1	Sirtuin 3IBA 01/2020
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2019
1	lanthionineIBA 10/2019
1	Peptides (Polypeptides)IBA 10/2019
1	LigandsIBA 10/2019
1	Peptide Hydrolases (Proteases)FDA Link 10/2019
1	Lisinopril (Prinivil)FDA LinkGeneric 10/2019
1	angiotensin I (1-7)IBA 10/2019
1	Angiotensin IIIBA 10/2019
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 10/2018
1	Connexin 43 (Connexin43)IBA 10/2018
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 10/2018
1	Phosphotransferases (Kinase)IBA 10/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Bovine Serum AlbuminIBA 01/2018
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2018
1	dapagliflozinIBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2017
1	CytokinesIBA 01/2016
1	Lipoprotein-XIBA 01/2016
1	Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)IBA 01/2016
1	Fibronectins (Fibronectin)IBA 01/2016
1	Streptozocin (Streptozotocin)FDA Link 01/2016
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2016
1	CholesterolIBA 01/2016
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2015
1	bindaritIBA 01/2015
1	clovamideIBA 10/2014
1	bardoxolone methylIBA 03/2013
1	2- cyano- 3,12- dioxooleana- 1,9(11)- dien- 28- oic acid ethyl amideIBA 03/2013
1	Transaminases (Aminotransferases)IBA 03/2013
1	bardoxoloneIBA 03/2013
1	TriterpenesIBA 03/2013
1	Ramipril (Altace)FDA LinkGeneric 01/2013
1	Glycoproteins (Glycoprotein)IBA 10/2012
1	LectinsIBA 10/2012
1	AnticoagulantsIBA 10/2012
1	P-SelectinIBA 07/2011
1	estropipate (Ogen)FDA LinkGeneric 07/2011
1	Complement Factor B (Factor B)IBA 07/2011
1	FibrinIBA 07/2011
1	PhytochemicalsIBA 11/2009
1	Shiga Toxins (Vero Toxin)IBA 07/2008
1	Virulence Factors (Pathogenicity Factors)IBA 07/2008

Therapy/Procedure

3	Therapeutics 01/2018 - 01/2015